The U.S.-China Science and Technology Cooperation Agreement (STA), a cornerstone of bilateral scientific collaboration for over four decades, was renewed in December 2024 after protracted negotiations. This renewal comes amid escalating trade tensions and heightened scrutiny of Chinese nationals in the United States, including visa restrictions. Despite these geopolitical headwinds, the updated STA preserves a vital framework for continued cooperation between U.S. and Chinese scientists.
Scientific collaboration between the two countries has yielded significant advances, particularly in human health. Joint efforts have contributed to preventing millions of birth defects, improving seasonal influenza vaccines through surveillance, and curbing the spread of HIV/AIDS within China’s vast population. Beyond health, cooperative research has spanned diabetes, heart disease, cancer, energy efficiency, and agricultural pest management. These achievements have been underpinned by the STA’s provisions ensuring transparency and intellectual property protection, especially following its 2018 updates.
China’s rise as a scientific peer to the United States reflects its substantial investments in education and research infrastructure. Since the STA’s inception, China has dramatically expanded its higher education system, now graduating more than twice the number of college students as the U.S. and awarding nearly as many PhDs annually. Notably, China produces more STEM PhDs than the United States, contributing to prolific joint research outputs. In 2015, Chinese co-authors surpassed the United Kingdom as the top partners for U.S. researchers.
However, since 2018, the number of joint U.S.-China scientific publications has declined, correlating with the launch of the Department of Justice’s China Initiative and deteriorating bilateral relations. This decline has not been offset by increased collaboration with other partners, and studies suggest that investigations targeting U.S. scientists of Chinese descent have negatively impacted overall U.S. scientific productivity.
Maintaining U.S. leadership in global science necessitates engagement with the best international research, increasingly including China. Collaboration accelerates progress in fields such as artificial intelligence, life sciences, climatology, and physics. Moreover, cooperative ties provide the U.S. with insights into China’s scientific landscape, facilitating dialogue on shared concerns.
The STA, first signed in 1979, primarily governs government-to-government scientific cooperation, emphasizing principles such as scientific integrity, transparency, respect for human subjects, and intellectual property protection. It has fostered breakthroughs in health, environmental technology, and disciplines like paleontology, while also encouraging cooperation beyond government entities, including universities and laboratories.
The 2024 renewal introduced three key U.S.-driven changes. First, the agreement’s scope was narrowed to focus exclusively on hard sciences and government-level cooperation, excluding nongovernmental scholarly activities and social sciences previously encompassed. This shift reflects differing interpretations: the U.S. viewed the STA as governing government activities only, whereas China saw it as supporting broader scientific cooperation.
Second, the updated STA includes explicit commitments to ensure the safety, well-being, and fair treatment of scientists engaged in cooperative activities. It obligates both parties to facilitate prompt entry and exit of personnel and equipment, provide access to relevant resources, and prohibits arbitrary detention, harassment, or exit bans related to cooperation.
Third, an annex mandates data transparency and reciprocity, establishing a mechanism for exchanging government data. This addresses challenges posed by China’s 2021 Data Security Law, which has complicated data sharing.
Despite these revisions, the STA faces implementation challenges. The narrowed scope limits its direct applicability to nongovernmental institutions, which constitute much of the scientific enterprise. Additionally, expanding export control regulations in both countries broadly define national security concerns, potentially restricting scientific collaboration. Furthermore, significant reductions in U.S. government funding for science and technology research, coupled with restrictions on sharing National Institutes of Health funding with international collaborators, undermine cooperative potential.
Potential pathways to sustain cooperation include nongovernmental institutions voluntarily endorsing the STA’s principles to guide their interactions with Chinese counterparts. Strategically calibrated export controls could balance national security with the benefits of basic scientific research. Crucially, restoring robust funding and depoliticizing U.S. scientific research agendas are essential to maintaining a vibrant scientific ecosystem capable of meaningful international collaboration.
Overall, the renewed STA preserves a critical, if constrained, channel for U.S.-China scientific engagement. While government-to-government cooperation remains limited, the agreement signals continued commitment to responsible collaboration and supports nongovernmental scientists who drive the majority of joint research. In a period of geopolitical uncertainty, the STA remains a valuable instrument for fostering scientific progress and dialogue between the world’s two leading research powers.
U.S. and China Renew Science and Technology Cooperation Agreement Amid Geopolitical Strains In December 2024, the United States and China signed an extension of their Science and Technology Cooperation Agreement (STA), reaffirming a framework for government-to-government scientific collaboration. While the upd... Read the full IIPLA article: https://iipla.org/news/u-s-and-china-renew-science-and-technology-cooperation-agreement-amid-geopolitical-strains